secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001193125-25-280247
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC updates ORIC-944 dose exploration data in corporate presentation
---------------------------------------------------------------------

- ORIC furnished updated ORIC-944 data slides for investor presentations (Exhibit 99.1).
- No specific numerical data or endpoints from the slides were disclosed in the filing.
- The presentation is for future use and does not contain financial results or guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312525280247/0001193125-25-280247-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312525280247/d898404d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-280247

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer